Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013

Watchlist Manager
Dr Sulaiman Al-Habib Medical Services Group Co Logo
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Watchlist
Price: 280 SAR -0.5% Market Closed
Market Cap: 98B SAR
Have any thoughts about
Dr Sulaiman Al-Habib Medical Services Group Co?
Write Note
Section:
 

Relative Value

The Relative Value of one Dr Sulaiman Al-Habib Medical Services Group Co stock under the Base Case scenario is 314.71 SAR. Compared to the current market price of 280 SAR, Dr Sulaiman Al-Habib Medical Services Group Co is Undervalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
314.71 SAR
Undervaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.3
P/S
P/S
Price to Sales
9.3
vs History
37
vs Industry
13
Median 3Y
9.7
Median 5Y
9
Industry
2.3
Forward
8.7
More Details
44
P/E
P/E
Price to Earnings
44
vs History
55
vs Industry
9
Median 3Y
46.1
Median 5Y
44.8
Industry
23.1
Forward
43.1
More Details
32
P/OCF
P/OCF
Price to OCF
32
vs History
23
vs Industry
12
Median 3Y
31.1
Median 5Y
28.8
Industry
14.2
More Details
63.2
P/FCFE
P/FCFE
Price to FCFE
63.2
vs History
25
vs Industry
4
Median 3Y
60.6
Median 5Y
45.2
Industry
20.1
More Details
14
P/B
P/B
Price to Book Value
14
vs History
28
vs Industry
4
Median 3Y
14
Median 5Y
12.5
Industry
2.2
More Details
9.7
EV/S
EV/S
Enterprise Value to Sales
9.7
vs History
33
vs Industry
12
Median 3Y
9.8
Median 5Y
9.2
Industry
2.4
Forward
9.1
More Details
28.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
28.4
vs History
38
vs Industry
6
Median 3Y
29.6
Median 5Y
27.9
Industry
5
More Details
39
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
39
vs History
37
vs Industry
6
Median 3Y
39.9
Median 5Y
37.4
Industry
12.7
Forward
36.3
More Details
45.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
45.3
vs History
42
vs Industry
7
Median 3Y
46.7
Median 5Y
45.1
Industry
17.1
Forward
43.3
More Details
33.6
EV/OCF
EV/OCF
Enterprise Value to OCF
33.6
vs History
18
vs Industry
13
Median 3Y
31.8
Median 5Y
29
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
0
Median 3Y
62
Median 5Y
48.2
Industry
18
More Details
6.8
EV/IC
EV/IC
Enterprise Value to IC
6.8
vs History
69
vs Industry
10
Median 3Y
8.4
Median 5Y
8
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Dr Sulaiman Al-Habib Medical Services Group Co Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
US
HCA Healthcare Inc
NYSE:HCA
78.6B USD 1.1 13.3 8.3 10.9
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
24.1B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
20B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
129.6B CNY 6.3 35.7 26.9 26.9
MY
IHH Healthcare Bhd
KLSE:IHH
62.8B MYR 2.7 23.7 12.8 18.5
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.5 105.1 72.9 86.9
US
Tenet Healthcare Corp
NYSE:THC
12.3B USD 0.6 3.9 5.2 6.6
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.3 100.4 41.8 57.3
US
Universal Health Services Inc
NYSE:UHS
12B USD 0.8 11.7 7.8 10.7
TH
Bangkok Dusit Medical Services PCL
SET:BDMS
389.4B THB 3.6 24.9 15.1 19.6

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.